Crossmark

Combination Glucose-Lowering Therapy Plans in T2DM: Case-Based Considerations

Crossref DOI link: https://doi.org/10.1007/s12325-018-0694-0

Published Online: 2018-05-18

Published Print: 2018-07

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Blonde, Lawrence http://orcid.org/0000-0003-0492-6698
Dipp, Susana

Cadena, Daniel
Funding

Funding for this research was provided by:

Boehringer Ingelheim (N/A)
License Information

License valid from 2018-05-18
More Information

Article History

Received: 13 December 2017

First Online: 18 May 2018

Change Date: 9 June 2018

Change Type: Correction

Change Details: The article “Combination Glucose-Lowering Therapy Plans in T2DM: Case-Based Considerations”.